Morning Briefing
Summaries of health policy coverage from major news organizations
Walgreens-Rite Aid Deal Latest In Series Of High-Profile Mergers To Be Thwarted By Antitrust Enforcers
The Wall Street Journal: Walgreens, Rite Aid End $9.4 Billion Merger
Walgreens Boots Alliance Inc. and Rite Aid Corp. scrapped their $9.4 billion merger agreement, the latest in a series of high-profile deals to be derailed by antitrust enforcers. Instead, Walgreens said it would seek to buy half of Rite RAD -26.46% Aid’s stores for $5.18 billion in cash. Executives said they had crafted the smaller deal to address regulatory issues, but antitrust experts said it doesn’t eliminate competition concerns. (Terlep and Kendall, 6/29)
Bloomberg: Walgreens Gives Up On Rite Aid Deal, Will Buy Stores Instead
The new agreement ends a saga that dragged on for more than a year and a half as the companies struggled to get approval from regulators. On Thursday, they said they would scrap the $7.37 billion takeover, and instead Walgreens will pay $5.18 billion to buy 2,186 stores, leaving Rite Aid as a regional chain. “This deal is much simpler,” Walgreens Chief Executive Officer Stefano Pessina said on a conference call. “It is an asset deal so it is less controversial.” (Langreth, 6/29)
